Cargando…
Targeting Autophagy as a Strategy for Developing New Vaccines and Host-Directed Therapeutics Against Mycobacteria
Mycobacterial disease is an immense burden worldwide. This disease group includes tuberculosis, leprosy (Hansen’s disease), Buruli Ulcer, and non-tuberculous mycobacterial (NTM) disease. The burden of NTM disease, both pulmonary and ulcerative, is drastically escalating globally, especially in devel...
Autores principales: | Strong, Emily J., Lee, Sunhee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840607/ https://www.ncbi.nlm.nih.gov/pubmed/33519771 http://dx.doi.org/10.3389/fmicb.2020.614313 |
Ejemplares similares
-
FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy
por: Wang, Jia, et al.
Publicado: (2022) -
Interfering With DNA Decondensation as a Strategy Against Mycobacteria
por: Scutigliani, Enzo M., et al.
Publicado: (2018) -
Autophagy-activating strategies to promote innate defense against mycobacteria
por: Kim, Yi Sak, et al.
Publicado: (2019) -
The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host's immune system
por: Batt, Sarah M., et al.
Publicado: (2020) -
Targeting Selective Autophagy as a Therapeutic Strategy for Viral Infectious Diseases
por: Liu, Yishan, et al.
Publicado: (2022)